Tolentino notes that more research is needed on this one
Although GHK-Cu peptide is commonly sold as an injectable solution for research purposes, the compound is included in a variety of topical skincare formulations, which are marketed as anti-aging products and available to the general public
Healing occurs through restoration of both the intestinal and cutaneous defects, with biomechanical testing confirming the treated areas can withstand normal physiological pressures without leakage
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage